RAPT Therapeutics shares are trading lower after multiple firms downgraded the stock.
Portfolio Pulse from Benzinga Newsdesk
RAPT Therapeutics shares have declined following downgrades from multiple firms.
February 21, 2024 | 4:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RAPT Therapeutics' stock price has decreased due to downgrades by multiple firms.
Analyst ratings have a significant impact on stock prices. The downgrades from multiple firms suggest a negative outlook on RAPT Therapeutics, likely leading to decreased investor confidence and a drop in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100